SEC 13F Intelligence

Birchview Capital, LP / PHAT

Birchview Capital, LP’s Phathom Pharmaceuticals Inc Position

Does Birchview Capital, LP own Phathom Pharmaceuticals Inc (PHAT)? Yes195.0K shares worth $2M (+1.23% of its 13F portfolio) as of Q1 2026.

Position Value
$2M
Q1 2026
Shares
195.0K
% of Portfolio
+1.23%
Quarters Held
4
currently held

Position History PHAT

Reported value by quarter
Q2 ’25: $239,750Q2 ’25Q3 ’25: $1MQ3 ’25Q4 ’25: $3MQ4 ’25Q1 ’26: $2MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026195.0K$2M+1.23%
Q4 2025195.0K$3M+1.89%
Q3 202585.0K$1M+0.76%
Q2 202525.0K$239,750+0.24%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of PHAT.